CLINICAL STUDY
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency
Luis Gruberg, MD*,
Gary S. Mintz, MD*,
Roxana Mehran, MD ,
George Dangas, MD, PhD,
Alexandra J. Lansky, MD,
Kenneth M. Kent, MD, PhD*,
Augusto D. Pichard, MD*,
Lowell F. Satler, MD* and
Martin B. Leon, MD
* Cardiac Catheterization Laboratory, Washington Hospital Center, Washington, DC, USA
Cardiovascular Research Foundation, New York, New York, USA
Manuscript received January 21, 2000;
revised manuscript received April 19, 2000,
accepted June 19, 2000.
Reprint requests and correspondence: Dr. Gary S. Mintz, Washington Hospital Center, 110 Irving Street NW, Suite 4B-1, Washington, DC 20010
gsm1{at}mhg.edu
BACKGROUND
Acute deterioration in renal function is a recognized complication after coronary angiography and intervention.
OBJECTIVES
The goal of this study was to determine the impact on acute and long-term mortality and morbidity of contrast-induced deterioration in renal function after coronary intervention.
METHODS
We studied 439 consecutive patients who had a baseline serum creatinine  1.8 mg/dL (159.1 µmol/L) who were not on dialysis who underwent percutaneous coronary intervention in a tertiary referral center. All patients were hydrated before the procedure, and almost all received ioxaglate meglumine; 161 (37%) patients had an increase in serum creatinine 25% within 48 h or required dialysis and 278 (63%) did not. In-hospital and out-of-hospital clinical events (death, myocardial infarction, repeat revascularization) were assessed by source documentation.
RESULTS
Independent predictors of renal function deterioration were left ventricular ejection fraction (p = 0.02) and contrast volume (p = 0.01). In-hospital mortality was 14.9% for patients with further renal function deterioration versus 4.9% for patients with no creatinine increase (p = 0.001); other complications were also more frequent. Thirty-one patients required hemodialysis; their in-hospital mortality was 22.6%. Four patients were discharged on chronic dialysis. The cumulative one-year mortality was 45.2% for those who required dialysis, 35.4% for those who did not require dialysis and 19.4% for patients with no creatinine increase (p = 0.001). Independent predictors of one-year mortality were creatinine elevation (p = 0.0001), age (p = 0.03) and vein graft lesion location (p = 0.08).
CONCLUSIONS
For patients with pre-existing renal insufficiency, renal function deterioration after coronary intervention is a marker for poor outcomes. This is especially true for patients who require dialysis.
|
Abbreviations and Acronyms
| | CI | = confidence interval | | CrCl | = creatinine clearance | | CRI | = chronic renal insufficiency | | MI | = myocardial infarction | | OR | = odds ratio |
|
This article has been cited by other articles:
|
|
|
|
 
D. Kiski, W. Stepper, E. Brand, G. Breithardt, and H. Reinecke
Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial
Nephrol. Dial. Transplant.,
November 9, 2009;
(2009)
gfp582v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Spargias, E. Adreanides, E. Demerouti, A. Gkouziouta, A. Manginas, G. Pavlides, V. Voudris, and D. V. Cokkinos
Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Circulation,
November 3, 2009;
120(18):
1793 - 1799.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Brown, C. A. Block, D. J. Malenka, G. T. O'Connor, A. C. Schoolwerth, and C. A. Thompson
Sodium Bicarbonate Plus N-Acetylcysteine Prophylaxis: A Meta-Analysis
J. Am. Coll. Cardiol. Intv.,
November 1, 2009;
2(11):
1116 - 1124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. J. Hoste, J. J. De Waele, S. A. Gevaert, S. Uchino, and J. A. Kellum
Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis
Nephrol. Dial. Transplant.,
August 23, 2009;
(2009)
gfp389v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Palevsky
Defining Contrast-Induced Nephropathy
Clin. J. Am. Soc. Nephrol.,
July 1, 2009;
4(7):
1151 - 1153.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Solomon, R. Mehran, M. K. Natarajan, S. Doucet, R. E. Katholi, C. S. Staniloae, S. K. Sharma, M. Labinaz, J. L. Gelormini, and B. J. Barrett
Contrast-Induced Nephropathy and Long-Term Adverse Events: Cause and Effect?
Clin. J. Am. Soc. Nephrol.,
July 1, 2009;
4(7):
1162 - 1169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Elahi, S. Asopa, A. Pflueger, N. Hakim, and B. Matata
Acute kidney injury following cardiac surgery: impact of early versus late haemofiltration on morbidity and mortality
Eur. J. Cardiothorac. Surg.,
May 1, 2009;
35(5):
854 - 863.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Morikawa, T. Sone, H. Tsuboi, H. Mukawa, I. Morishima, M. Uesugi, Y. Morita, Y. Numaguchi, K. Okumura, and T. Murohara
Renal Protective Effects and the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide
J. Am. Coll. Cardiol.,
March 24, 2009;
53(12):
1040 - 1046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Goldfarb, P. A. McCullough, J. McDermott, and S. B. Gay
Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional Cardiology
Mayo Clin. Proc.,
February 1, 2009;
84(2):
170 - 179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Weinreb
Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT?
Radiology,
October 1, 2008;
249(1):
3 - 8.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. From, B. J. Bartholmai, A. W. Williams, S. S. Cha, and F. S. McDonald
Mortality Associated With Nephropathy After Radiographic Contrast Exposure
Mayo Clin. Proc.,
October 1, 2008;
83(10):
1095 - 1100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Langner, S. Stumpe, M. Kirsch, M. Petrik, and N. Hosten
No Increased Risk for Contrast-Induced Nephropathy after Multiple CT Perfusion Studies of the Brain with a Nonionic, Dimeric, Iso-Osmolal Contrast Medium
AJNR Am. J. Neuroradiol.,
September 1, 2008;
29(8):
1525 - 1529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Solomon
Contrast-Induced Acute Kidney Injury: Is There a Risk after Intravenous Contrast?
Clin. J. Am. Soc. Nephrol.,
September 1, 2008;
3(5):
1242 - 1243.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Fei, X. Du, Q. Yang, Y. Shen, P. Li, J. Liao, and K. Li
64-MDCT Coronary Angiography: Phantom Study of Effects of Vascular Attenuation on Detection of Coronary Stenosis
Am. J. Roentgenol.,
July 1, 2008;
191(1):
43 - 49.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mockel, M. Radovic, Y. Kuhnle, V. Combe, J. Waigand, S. Schroder, R. Dietz, U. Frei, and K.-U. Eckardt
Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography
Nephrol. Dial. Transplant.,
May 1, 2008;
23(5):
1588 - 1594.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. McCullough
Contrast-Induced Acute Kidney Injury
J. Am. Coll. Cardiol.,
April 15, 2008;
51(15):
1419 - 1428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Nusca, R. Melfi, and G. Di Sciascio
Review: Percutaneous coronary interventions and statins therapy
Therapeutic Advances in Cardiovascular Disease,
April 1, 2008;
2(2):
101 - 107.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. K. Inrig, U. D. Patel, L. P. Briley, L. She, B. S. Gillespie, J. D. Easton, E. J. Topol, and L. A. Szczech
Mortality, kidney disease and cardiac procedures following acute coronary syndrome
Nephrol. Dial. Transplant.,
March 1, 2008;
23(3):
934 - 940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rudnick and H. Feldman
Contrast-Induced Nephropathy: What Are the True Clinical Consequences?
Clin. J. Am. Soc. Nephrol.,
January 1, 2008;
3(1):
263 - 272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. T. C. Wong and M. G. Irwin
Contrast-induced nephropathy
Br. J. Anaesth.,
October 1, 2007;
99(4):
474 - 483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. O Onbasili, Y. Yeniceriglu, P. Agaoglu, A. Karul, T. Tekten, H. Akar, and G. Discigil
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
Heart,
June 1, 2007;
93(6):
698 - 702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Deo, M. Fogel, and S. E. Cowper
Nephrogenic Systemic Fibrosis: A Population Study Examining the Relationship of Disease Development to Gadolinium Exposure
Clin. J. Am. Soc. Nephrol.,
March 1, 2007;
2(2):
264 - 267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Jo, T.-J. Youn, B.-K. Koo, J.-S. Park, H.-J. Kang, Y.-S. Cho, W.-Y. Chung, G.-W. Joo, I.-H. Chae, D.-J. Choi, et al.
Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study: A Randomized Controlled Trial
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
924 - 930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Pannu, N. Wiebe, M. Tonelli, and for the Alberta Kidney Disease Network
Prophylaxis Strategies for Contrast-Induced Nephropathy
JAMA,
June 21, 2006;
295(23):
2765 - 2779.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Michishita and Z. Fujii
A Novel Contrast Removal System From the Coronary Sinus Using an Adsorbing Column During Coronary Angiography in a Porcine Model
J. Am. Coll. Cardiol.,
May 2, 2006;
47(9):
1866 - 1870.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G., I. I., N. E., A. E.D., M. G.S., K. N.N., L. A.J., M. I., S. G.W., M. J.W., et al.
Radiocontrast-Induced Acute Renal Failure--Impact beyond the Acute Phase: Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Relation to Chronic Kidney Disease and Hemodynamic Variables. Am J Cardiol 95: 13-19, 2005
J. Am. Soc. Nephrol.,
March 1, 2006;
17(3):
595 - 599.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Barrett and P. S. Parfrey
Preventing Nephropathy Induced by Contrast Medium
N. Engl. J. Med.,
January 26, 2006;
354(4):
379 - 386.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Bagshaw, F. A. McAlister, B. J. Manns, and W. A. Ghali
Acetylcysteine in the Prevention of Contrast-Induced Nephropathy: A Case Study of the Pitfalls in the Evolution of Evidence
Arch Intern Med,
January 23, 2006;
166(2):
161 - 166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Cowburn, H. Patel, R. R. Pipes, and J. D. Parker
Contrast nephropathy post cardiac resynchronization therapy: An under-recognized complication with important morbidity
Eur J Heart Fail,
August 1, 2005;
7(5):
899 - 903.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Heinrich, M. K. Kuhlmann, A. Grgic, M. Heckmann, B. Kramann, and M. Uder
Cytotoxic Effects of Ionic High-osmolar, Nonionic Monomeric, and Nonionic Iso-osmolar Dimeric Iodinated Contrast Media on Renal Tubular Cells in Vitro
Radiology,
June 1, 2005;
235(3):
843 - 849.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Bagshaw and W. A. Ghali
Theophylline for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis
Arch Intern Med,
May 23, 2005;
165(10):
1087 - 1093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, et al.
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
JAMA,
May 4, 2005;
293(17):
2126 - 2130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Mehta
Acute Renal Failure and Cardiac Surgery: Marching in Place or Moving Ahead?
J. Am. Soc. Nephrol.,
January 1, 2005;
16(1):
12 - 14.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Marenzi, G. Lauri, E. Assanelli, J. Campodonico, M. De Metrio, I. Marana, M. Grazi, F. Veglia, and A. L. Bartorelli
Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction
J. Am. Coll. Cardiol.,
November 2, 2004;
44(9):
1780 - 1785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Spargias, E. Alexopoulos, S. Kyrzopoulos, P. Iacovis, D. C. Greenwood, A. Manginas, V. Voudris, G. Pavlides, C. E. Buller, D. Kremastinos, et al.
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Circulation,
November 2, 2004;
110(18):
2837 - 2842.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Gupta, Y. Birnbaum, and B. F. Uretsky
The renal patient with coronary artery disease: Current concepts and dilemmas
J. Am. Coll. Cardiol.,
October 6, 2004;
44(7):
1343 - 1353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Mehran, E. D. Aymong, E. Nikolsky, Z. Lasic, I. Iakovou, M. Fahy, G. S. Mintz, A. J. Lansky, J. W. Moses, G. W. Stone, et al.
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation
J. Am. Coll. Cardiol.,
October 6, 2004;
44(7):
1393 - 1399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V. Kshirsagar, C. Poole, A. Mottl, D. Shoham, N. Franceschini, G. Tudor, M. Agrawal, C. Denu-Ciocca, E. Magnus Ohman, and W. F. Finn
N-Acetylcysteine for the Prevention of Radiocontrast Induced Nephropathy: A Meta-Analysis of Prospective Controlled Trials
J. Am. Soc. Nephrol.,
March 1, 2004;
15(3):
761 - 769.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Gami and V. D. Garovic
Contrast Nephropathy After Coronary Angiography
Mayo Clin. Proc.,
February 1, 2004;
79(2):
211 - 219.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. M. Sadeghi, G. W. Stone, C. L. Grines, R. Mehran, S. R. Dixon, A. J. Lansky, M. Fahy, D. A. Cox, E. Garcia, J. E. Tcheng, et al.
Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction
Circulation,
December 2, 2003;
108(22):
2769 - 2775.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Stone, P. A. McCullough, J. A. Tumlin, N. E. Lepor, H. Madyoon, P. Murray, A. Wang, A. A. Chu, G. L. Schaer, M. Stevens, et al.
Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy: A Randomized Controlled Trial
JAMA,
November 5, 2003;
290(17):
2284 - 2291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Marenzi, I. Marana, G. Lauri, E. Assanelli, M. Grazi, J. Campodonico, D. Trabattoni, F. Fabbiocchi, P. Montorsi, and A. L. Bartorelli
The Prevention of Radiocontrast-Agent-Induced Nephropathy by Hemofiltration
N. Engl. J. Med.,
October 2, 2003;
349(14):
1333 - 1340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Herzog
How to Manage the Renal Patient with Coronary Heart Disease: The Agony and the Ecstasy of Opinion-Based Medicine
J. Am. Soc. Nephrol.,
October 1, 2003;
14(10):
2556 - 2572.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and
Management of Patients Undergoing Percutaneous Coronary Revascularization
Ann Intern Med,
July 15, 2003;
139(2):
123 - 136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Thompson and S. L. King
Acetylcysteine and Fenoldopam: Promising New Approaches for Preventing Effects of Contrast Nephrotoxicity
Crit. Care Nurse,
June 1, 2003;
23(3):
39 - 46.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Provenchere, G. Plantefeve, G. Hufnagel, E. Vicaut, C. de Vaumas, J.-B. Lecharny, J.-P. Depoix, F. Vrtovsnik, J.-M. Desmonts, and I. Philip
Renal Dysfunction After Cardiac Surgery with Normothermic Cardiopulmonary Bypass: Incidence, Risk Factors, and Effect on Clinical Outcome
Anesth. Analg.,
May 1, 2003;
96(5):
1258 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. V. Freeman, R. H. Mehta, W. Al Badr, J. V. Cooper, E. Kline-Rogers, and K. A. Eagle
Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors
J. Am. Coll. Cardiol.,
March 5, 2003;
41(5):
718 - 724.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kay, W. H. Chow, T. M. Chan, S. K. Lo, O. H. Kwok, A. Yip, K. Fan, C. H. Lee, and W. F. Lam
Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention: A Randomized Controlled Trial
JAMA,
February 5, 2003;
289(5):
553 - 558.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-G. i Shyu, J.-J. Cheng, and P. Kuan
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure
J. Am. Coll. Cardiol.,
October 16, 2002;
40(8):
1383 - 1388.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Rihal, S. C. Textor, D. E. Grill, P. B. Berger, H. H. Ting, P. J. Best, M. Singh, M. R. Bell, G. W. Barsness, V. Mathew, et al.
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Circulation,
May 14, 2002;
105(19):
2259 - 2264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Mueller, G. Buerkle, H. J. Buettner, J. Petersen, A. P. Perruchoud, U. Eriksson, S. Marsch, and H. Roskamm
Prevention of Contrast Media-Associated Nephropathy: Randomized Comparison of 2 Hydration Regimens in 1620 Patients Undergoing Coronary Angioplasty
Arch Intern Med,
February 11, 2002;
162(3):
329 - 336.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Ruilope, D. J. van Veldhuisen, E. Ritz, and T. F. Luscher
Renal function: the Cinderella of cardiovascular risk profile
J. Am. Coll. Cardiol.,
December 1, 2001;
38(7):
1782 - 1787.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
